Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-26 @ 2:46 AM
Study NCT ID:
NCT05640102
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2022-11-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-28
First Submit QC Date:
None
Study First Post Date:
2022-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-11
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED